LicianPro

EKSO stock

Ekso Bionics Holdings Inc (EKSO) financials · rev $71.6M

Compare AAPL vs MSFT

Ekso Bionics Holdings Inc (EKSO) rev $71.6M.

Annual income statement
LineFY2026FY2025Pro (3 older periods with Lician Pro)
Revenue$71.60M$84.38M
Cost of Revenue$88.69M$115.31M
Gross Profit−$17.09M−$30.93M
Operating Income−$37.50M−$55.33M
Net Income−$50.32M−$72.73M
EPS (Diluted)−$0.36−$0.53
Unlock 5 years of statements: Lician Pro $149/yr
Annual balance sheet
LineFY2026FY2025Pro (3 older periods with Lician Pro)
Total Assets$325.87M$304.20M
Current Assets$44.25M$6.41M
Cash & Equivalents$9.66M$2.40M
PP&E$32.08M$10.92M
Total Liabilities$143.84M$228.05M
Current Liabilities$86.89M$157.63M
Short-term Debt$3.37M—
Long-term Debt$474.00K$12.00M
Total Debt$3.84M$12.00M
Shareholders' Equity$180.03M$76.15M
Retained Earnings−$199.46M−$149.14M

† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).

Annual cash flow
LineFY2026FY2025Pro (3 older periods with Lician Pro)
Operating Cash Flow$39.07M−$11.80M
CapEx$26.88M$188.00K
Investing Cash Flow−$25.17M−$188.00K
Financing Cash Flow−$6.63M$6.63M
Net Change in Cash$7.27M−$5.32M
Free Cash Flow$12.19M−$11.99M

Source: Company filings with the SEC (EDGAR) · Latest period FY2026

These statements as JSON? API free 100/day

FAQ

What is EKSO P/E and revenue?

Ekso Bionics Holdings Inc (EKSO) rev $71.6M.

What is EKSO revenue?

Ekso Bionics Holdings Inc last cached revenue is $71.6M (FY2026).

Is EKSO profitable?

Ekso Bionics Holdings Inc last cached net income is -$50.3M (FY2026).

What are EKSO total assets?

Ekso Bionics Holdings Inc last cached total assets are $325.9M (FY2026).

What is EKSO free cash flow?

Ekso Bionics Holdings Inc last cached free cash flow is $12.2M (FY2026).

Not investment advice. Figures as reported in company filings, not a live feed.